menuMenu Our Work We seek to help solve the world's most urgent health problems and to improve healthcare around the world. Our key areas Oncology Vaccines Infectious diseases Hepatitis Antibiotic resistance HIV (under construction) Immunology Diabetes Cardiology (under construction) Animal health GALENUS PRIZE Recognition of Medical and Scientific Research & Innovation: MSD Belgium & Luxembourg won the Galenus Prize for following innovative MSD drugs for human consumption: Keytruda® (2016), Victrelis® (2012), Cancidas® (2008), Gardasil® (2007), Crixivan® (1997), Zocor® (1990). Learn more Focus on research Find out how our research is helping to address some of the world's unmet medical needs. Research at MSD © MSD Belgium BE-NON-00320. Date of last revision: 12/2019 Legal Notice Terms of Use Data Protection Cookie Preferences This Site Uses Cookies and Your Privacy Choice Is Important to Us We suggest you choose Customize my Settings to make your individualized choices. Accept Cookies means that you are choosing to accept third-party Cookies and that you understand this choice. See our Privacy Policy Reject Cookies Accept Cookies Customize my Settings

menuMenu OUR HISTORY We've done great things in the past. Today, we're doing great things for the future. MSD has been pioneering medical progress for more than 125 years. During this time, we have been able to significantly improve treatment of numerous serious and chronic diseases. In the past 50 years alone, MSD has brought 40 new medicines onto the market - many of them representing a new class of active ingredients. The field of vaccines is part of MSD's history. For over 100 years, we have been developing vaccines that help protect the lives of millions of people. They contribute to the fact that highly infectious diseases, such as rubella, are rare diseases today and certain HPV-related diseases can be prevented. Learn more MSD in Belgium The first Belgian subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA was founded in Brussels in 1965. The global merger between MSD and Shering-Plough was in 2009 and since that time, the company has strong local roots. Our production and packaging site in the Flanders at Heist-op-den Berg has been operational since 1973 and is an important employer in the region. Today, MSD employes more than 69.000 people worldwide in over 140 countries (as of 2017) and is one of the world’s leading research-based biopharmaceutical companies. In Belgium and Luxembourg, 1220 empoyees work at four different locations (as of 01/19). © MSD Belgium BE-NON-00320. Date of last revision: 12/2019 Legal Notice Terms of Use Data Protection Cookie Preferences This Site Uses Cookies and Your Privacy Choice Is Important to Us We suggest you choose Customize my Settings to make your individualized choices. Accept Cookies means that you are choosing to accept third-party Cookies and that you understand this choice. See our Privacy Policy Reject Cookies Accept Cookies Customize my Settings